
More than 112,000 bottles of Amazon’s store-brand pain reliever are getting pulled off shelves after customers spotted discolored tablets inside.
Quick Take
- Aurobindo Pharma USA voluntarily recalled 112,932 bottles of Amazon Basic Care Extra Strength Acetaminophen on September 18, 2026.
- The recall covers 500-milligram caplets sold in 200-count, 500-count, and 1,000-count bottles, tied to specific lot numbers.
- Consumer complaints about discolored tablets triggered the action, and a health hazard evaluation found no safety or effectiveness impact.
- No adverse health events have been reported, and the Food and Drug Administration (FDA) has not yet assigned a formal risk classification.
What Triggered The Recall And Who Is Responsible
Aurobindo Pharma USA Inc. started the voluntary recall on September 18, 2026. The company makes the acetaminophen sold under Amazon’s Basic Care label. The FDA later listed the action in its enforcement report on October 2. The recall reason is simple: shoppers noticed discolored tablets and complained.
Amazon’s branding sits on the bottle, but Aurobindo is the manufacturer named as the recalling firm. That split matters. Amazon sells the product and contacted affected customers directly, while Aurobindo carries the manufacturing and quality responsibility behind the scenes.
Checking Your Medicine Cabinet: Lots And Sizes
The recall only touches specific batches, not every bottle of Amazon acetaminophen ever sold. Check your bottle against these lot numbers: ACD125040A for 200-count bottles, ACD124036A, ACD124030A, and ACD124042A for 500-count bottles, and ACD124048A for 1,000-count bottles. All carry 2027 expiration dates.
The breakdown by package size shows where most of the affected stock landed. Investigators counted 14,640 bottles of the 200-count size, 90,456 bottles of the 500-count size, and 7,836 bottles of the 1,000-count size. Added together, that reaches the reported total of 112,932 bottles.
No Injuries Reported, But Risk Level Still Undecided
Health officials say no one has reported getting sick from the discolored pills. A health hazard evaluation concluded the discoloration did not change the medicine’s safety or how well it works. That finding should ease worries for anyone who already swallowed one of the odd-colored caplets.
Still, the FDA has not yet handed down an official risk classification for this recall. Past discoloration recalls have landed in different categories depending on the details. A similar 2025 Amazon-distributed acetaminophen recall involving brown surface discoloration from Aurobindo ended up classified as Class II, the agency’s middle-tier category for temporary or reversible health effects.
Why Discoloration Recalls Keep Happening
This is not an isolated quirk. A review of recalls between 2016 and 2024 found 36 medicines pulled specifically over discoloration, with tablets making up more than half of those cases. Visual defects like this often move faster than lab results, because companies pull suspect batches before regulators finish confirming whether the color change means anything chemically.
The Food and Drug Administration’s own enforcement records back that pattern up. A 2024 Teva Pharmaceuticals recall, for example, involved blue tablets mixed in with inert white ones, a different cause but the same instinct to act on appearance first and investigate second. That approach favors caution over waiting for certainty, which is exactly what consumers should want from companies handling medicine people put in their bodies every day.
What Shoppers Should Do Right Now
Anyone holding an affected bottle should stop using it and check the lot number printed on the label. Amazon has already reached out to customers tied to the recalled batches through its order and messaging systems. Returning or discarding the product is the safest move until the FDA finalizes how serious it considers this particular recall to be.
An FDA enforcement report said more than 100,000 bottles of the Amazon brand of Extra Strength acetaminophen are under recall after reports of discolored tablets. https://t.co/vRJGOgvtCv
— KHOU 11 News Houston (@KHOU) October 13, 2026
Pharmaceutical recalls tied to appearance alone rarely end in tragedy, but they remind buyers that even trusted store brands rely on manufacturers most people never hear of. Reading labels and checking lot numbers takes thirty seconds and beats guessing whether that slightly off-color pill is worth the risk.
Sources:
foxbusiness.com, finance.yahoo.com, kagstv.com, thehill.com














